Horvath Clock vs GrimAge: Which Is More Accurate?

Two Generations of Epigenetic Aging Science

When Steve Horvath published his groundbreaking multi-tissue epigenetic clock in 2013, it transformed aging research by providing the first reliable molecular measure of biological age. Six years later, the same research group introduced GrimAge, an epigenetic clock specifically designed not just to estimate age but to predict how long you have left to live. These two clocks represent different generations and philosophies of biological age measurement, and understanding their differences is important for anyone using epigenetic testing to monitor their aging.

The Horvath Clock: The Pioneer

How It Was Built

The Horvath clock was the first multi-tissue epigenetic clock, designed to work across virtually any human tissue or cell type. Horvath analyzed DNA methylation data from over 8,000 samples representing 51 different tissues and cell types, using a machine learning approach called elastic net regression to identify the 353 CpG sites whose methylation levels most accurately predict chronological age.

Design Philosophy

The Horvath clock was trained to predict chronological age as accurately as possible. The idea was that deviations between the clock’s estimate and actual calendar age would reflect the pace of biological aging. If the clock reads older than your actual age, you may be aging faster than average; if it reads younger, you may be aging more slowly.

Strengths

Pan-tissue applicability: The Horvath clock’s greatest strength is its ability to work across diverse tissue types. This makes it uniquely valuable for comparing aging rates between different organs and for studying aging in tissues that are not easily sampled by blood draw.

Developmental sensitivity: The Horvath clock captures both developmental and aging-related methylation changes, providing a continuous age estimate from prenatal development through old age. This makes it useful for studying the full arc of biological aging.

Extensive validation: With over a decade of published research, the Horvath clock has been validated in thousands of studies across diverse populations, providing an extensive body of evidence for its associations with various health outcomes.

Limitations

Moderate mortality prediction: While Horvath clock age acceleration does predict mortality, the association is weaker than that of later clocks specifically designed for mortality prediction.

Limited intervention sensitivity: The Horvath clock may not detect the effects of short-term lifestyle interventions as readily as more recent clocks, which can be frustrating for individuals trying to monitor the impact of health changes.

Chronological age bias: Because the clock was trained to predict calendar age, it may underestimate the importance of certain aging-related changes that do not correlate strongly with time.

GrimAge: The Mortality Predictor

How It Was Built

GrimAge used a two-step approach that fundamentally changed the design philosophy of epigenetic clocks:

Step 1: DNA methylation data was used to create surrogates (proxies) for seven plasma proteins associated with mortality and morbidity, plus a smoking pack-years estimator. These methylation-based surrogates effectively capture the biological signals of these proteins without requiring actual blood protein measurement.

Step 2: These eight methylation surrogates, along with chronological age and sex, were combined into a composite score that was trained to predict time-to-death using longitudinal mortality data from the Framingham Heart Study.

The Seven Protein Surrogates

GrimAge incorporates methylation-based proxies for:

1. Adrenomedullin (ADM): A peptide involved in cardiovascular regulation
2. Beta-2 microglobulin (B2M): A marker of immune function and kidney health
3. Cystatin C: A measure of kidney function
4. GDF-15 (Growth Differentiation Factor 15): A stress-response cytokine associated with aging
5. Leptin: A hormone related to metabolism and body composition
6. PAI-1 (Plasminogen Activator Inhibitor 1): Involved in blood clotting and cardiovascular risk
7. TIMP-1 (Tissue Inhibitor of Metalloproteinases 1): Related to tissue remodeling

Plus a DNA methylation-based estimate of smoking pack-years, capturing one of the strongest environmental accelerators of aging.

Design Philosophy

GrimAge was designed with a fundamentally different goal: rather than predicting how old you are, it predicts how close you are to dying. This may sound grim (hence the name), but it makes GrimAge far more relevant for health assessment than clocks trained on chronological age.

Strengths

Superior mortality prediction: GrimAge is the strongest epigenetic predictor of time-to-death among established clocks. In head-to-head comparisons, GrimAge acceleration significantly outperforms Horvath clock acceleration in predicting all-cause mortality, cardiovascular mortality, and cancer incidence.

Health outcome associations: GrimAge acceleration is strongly associated with:

• Coronary heart disease
• Congestive heart failure
• Type 2 diabetes
• Lung function decline
• Physical and cognitive decline
• Cancer incidence

Captures environmental exposures: Through its smoking pack-years surrogate and protein proxies, GrimAge effectively captures the health impact of environmental exposures and lifestyle choices that first-generation clocks may miss.

Limitations

Blood-specific: Unlike the Horvath clock, GrimAge was designed for blood-based measurements and may not be directly applicable to other tissues.

Cumulative measure: GrimAge reflects cumulative biological aging, which means it may be slow to respond to recent lifestyle changes. Someone who quit smoking five years ago may still carry a GrimAge penalty from their smoking history.

Less transparency: The two-step design makes GrimAge somewhat harder to interpret mechanistically. When GrimAge shows acceleration, it can be difficult to determine which specific component is driving the result.

Cohort-specific calibration: GrimAge was calibrated primarily on the Framingham Heart Study cohort, which may limit its generalizability to other populations without recalibration.

Head-to-Head Comparison

Predicting Death

In multiple independent validation studies, GrimAge consistently outperforms the Horvath clock for mortality prediction. For example, in the Women’s Health Initiative study, each year of GrimAge acceleration was associated with a 20% increase in mortality risk, compared to a smaller effect for Horvath clock acceleration.

Predicting Disease

For cardiovascular disease, cancer, and metabolic disease prediction, GrimAge shows stronger and more consistent associations than the Horvath clock. The inclusion of protein surrogates related to cardiovascular function, immunity, and metabolism gives GrimAge a broader view of health-relevant biological aging.

Detecting Lifestyle Effects

Both clocks show associations with lifestyle factors, but they differ in sensitivity:

• Smoking: GrimAge is far more sensitive to smoking effects due to its explicit smoking surrogate
• BMI/obesity: Both clocks detect obesity-related acceleration, with GrimAge showing stronger effects
• Exercise: The Horvath clock and GrimAge both associate with physical activity, though the relationships are modest for both
• Diet: Mediterranean diet adherence shows associations with both clocks, with some studies finding GrimAge to be more responsive

Research Applications

GrimAge2: The Updated Version

In 2022, an updated version called GrimAge2 was published, incorporating additional protein surrogates and improved statistical methods. GrimAge2 shows:

• Stronger mortality prediction than the original GrimAge
• Better performance across diverse ancestry groups
• Improved association with cardiovascular and metabolic outcomes
• Greater sensitivity to certain lifestyle factors

Beyond Horvath and GrimAge: The Broader Landscape

PhenoAge

Developed by Morgan Levine, PhenoAge bridges the gap between first- and second-generation clocks. It was trained on a composite of clinical biomarkers associated with mortality risk and captures aspects of biological aging that overlap with but are distinct from both Horvath and GrimAge.

DunedinPACE

Rather than estimating cumulative biological age (like Horvath or GrimAge), DunedinPACE measures the current pace of aging. For monitoring interventions, DunedinPACE may be more responsive than either Horvath or GrimAge because it captures ongoing aging rate rather than accumulated aging.

Using Multiple Clocks

Many researchers and clinicians recommend examining results from multiple clocks rather than relying on any single measure. Each clock captures different aspects of the aging process, and discordance between clocks can itself be informative. For example, someone with normal Horvath age but accelerated GrimAge may have specific risk factors (such as smoking history or metabolic dysfunction) that GrimAge captures better.

Practical Guidance

For Consumer Testing

If you are considering epigenetic age testing:

• Choose a service that reports multiple clocks: This gives you the most complete picture
• For health risk assessment: Pay particular attention to GrimAge (or GrimAge2) results
• For intervention tracking: Consider services that include DunedinPACE alongside GrimAge
• Serial testing: Track changes over time rather than relying on a single measurement
• Manage expectations: No clock is perfect for individuals; use results as one data point among many

For Research

• Mortality studies: GrimAge is the preferred primary outcome measure
• Cross-tissue studies: The Horvath clock remains essential
• Intervention trials: Consider both GrimAge (for cumulative effects) and DunedinPACE (for pace changes)
• Report multiple clocks: Different clocks may show different results; transparency improves interpretability

The Bottom Line

The Horvath clock and GrimAge represent two generations of epigenetic aging science, each with distinct strengths. The Horvath clock remains valuable for its pan-tissue applicability and extensive research base, while GrimAge provides superior prediction of the outcomes that matter most: disease, disability, and death. For most practical purposes, GrimAge and its successors offer more health-relevant information, but the ideal approach is to examine multiple clocks together to build the most complete picture of biological aging.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional for personalized health guidance.